These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21654890)

  • 41. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema.
    Brar M; Yuson R; Kozak I; Mojana F; Cheng L; Bartsch DU; Oster SF; Freeman WR
    Retina; 2010 Mar; 30(3):383-9. PubMed ID: 20216291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.
    Parodi MB; Iacono P; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1647-51. PubMed ID: 25382074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of pan retinal photocoagulation on central macular thickness and visual acuity in proliferative diabetic retinopathy.
    Mukhtar A; Khan MS; Junejo M; Ishaq M; Akbar B
    Pak J Med Sci; 2016; 32(1):221-4. PubMed ID: 27022379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.
    Arevalo JF; Sanchez JG; Fromow-Guerra J; Wu L; Berrocal MH; Farah ME; Cardillo J; Rodríguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):735-43. PubMed ID: 19189118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema.
    Yeung L; Lima VC; Garcia P; Landa G; Rosen RB
    Ophthalmology; 2009 Jun; 116(6):1158-67. PubMed ID: 19395034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
    Payne JF; Wykoff CC; Clark WL; Bruce BB; Boyer DS; Brown DM;
    Ophthalmology; 2017 Jan; 124(1):74-81. PubMed ID: 27836430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of 3-D image reconstruction of spectral-domain OCT on outcome of grid laser photocoagulation for diffuse diabetic macular edema.
    Ophir A; Hanna R; Martinez MR
    Int J Ophthalmol; 2013; 6(6):836-43. PubMed ID: 24392334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema.
    Lavinsky D; Cardillo JA; Melo LA; Dare A; Farah ME; Belfort R
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4314-23. PubMed ID: 21345996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables.
    Browning DJ; Apte RS; Bressler SB; Chalam KV; Danis RP; Davis MD; Kollman C; Qin H; Sadda S; Scott IU;
    Retina; 2009 Mar; 29(3):300-5. PubMed ID: 19174719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion.
    Kang HM; Chung EJ; Kim YM; Koh HJ
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):501-8. PubMed ID: 22653439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
    Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between foveal ischemia and spectral-domain optical coherence tomography findings in ischemic diabetic macular edema.
    Lee DH; Kim JT; Jung DW; Joe SG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1080-5. PubMed ID: 23329668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema.
    Lee SN; Chhablani J; Chan CK; Wang H; Barteselli G; El-Emam S; Gomez ML; Kozak I; Cheng L; Freeman WR
    Am J Ophthalmol; 2013 May; 155(5):905-12. PubMed ID: 23394906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
    Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
    Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
    Kartasasmita AS; Takarai S; Switania A; Enus S
    Clin Ophthalmol; 2016; 10():2135-2140. PubMed ID: 27826179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.